RareResearch.AI
← Back to atlas

W371G

Category 2 — Moderately DestabilizingUncertain significanceTransmembrane · predictedSource card
TryptophanGlycine at position 371 · Transmembrane helix 3 · WFS1 (Wolframin)

Interactive 3D Structure

Wild-type reference
Wild-type W371 — hydrogen bond to R375
Fullscreen ↗
DynaMut2 mutant · W371G
Mutant G371 — hydrogen bond to S368 lost (9 contacts lost)
Fullscreen ↗

Bond changes · DynaMut2 interaction analysis

9 lost0 gained9 preserved
Interaction typeWild-type partnerMutant partnerStatus
Hydrogen bondD367D367Preserved
Hydrogen bondS368S368Preserved
Hydrogen bondF374F374Preserved
Hydrogen bondR375R375Preserved
Polar contactD367D367Preserved
Polar contactS368S368Preserved
Polar contactN373Lost
Polar contactF374F374Preserved
Polar contactR375R375Preserved
Aromatic / πF374Lost
Aromatic / πF397Lost
Van der WaalsK369K369Preserved
Van der WaalsN373Lost
Van der WaalsE394Lost
Van der WaalsF397Lost
HydrophobicF374Lost
HydrophobicE394Lost
HydrophobicF397Lost

Lost / gained / preserved interatomic contacts at the variant residue, from the DynaMut2 (Arpeggio) interaction analysis of the wild-type and energy-minimized mutant structures.

Computational Predictions

DynaMut2 ΔΔG
-2.34kcal/mol
Destabilising — large
AlphaMissense
0.908
likely pathogenic
AlphaFold pLDDT
80
model confidence
Schema
Cat 2
Category 2 — Moderately Destabilizing
ΔΔG confidence: Reduced confidence · Transmembrane
  • transmembrane position; predictor benchmarked on soluble proteins

This variant sits in the transmembrane band. The stability value was computed with a predictor benchmarked on water-soluble proteins. Published benchmarks of ddG predictors on membrane proteins report correlation below 0.4. Treat the magnitude as unreliable and the sign as weak evidence only.

Do not rank this value against a variant from a different region on ΔΔG alone.

Clinical Evidence

ClinVar classificationUncertain significance
Review statuscriteria provided, single submitter
Associated conditions
Population frequency (gnomAD v4)Ultra-rare · AF 0.0025%
cDNA changec.1111T>G
ClinVar accessionVCV001520543
Last evaluated2021/09/20 00:00

Observed at very low frequency in gnomAD.

Classified for1★ unverified submission

ClinVar classifies this variant as Uncertain significance, but does not state what it is classified for. ClinVar records no condition for this variant. A classification without a phenotype and an inheritance mode cannot be read as a statement about Wolfram syndrome risk or severity.

  • Phenotype scope is interpretation of submitted records. The computed values on this card (AlphaMissense, DynaMut2 ΔΔG, pLDDT) are measurements of the model, not of a patient.
  • Presentation cannot be generalised from neighbouring variants: one nucleotide over can present very differently. Structural similarity supports a mechanistic hypothesis, never a phenotype claim.

Review status: 1★ single submitter. ClinVar "conditions" is the union of all submissions; 0–1★ entries are submitted conditions, not documented phenotypes.

Population frequency
Global (all ancestries)
AF 0.0025% · 40 / 1,611,484 alleles
Homozygotes
1
Highest-frequency population
African / African American · AF 0.048%

Highest in African / African American: AF 0.048% (36 of 74,946 alleles), 19.4x the global figure. The global AF describes the general population, not the at-risk group.

1 homozygote reported in gnomAD v4 (1 African / African American). gnomAD excludes individuals with severe pediatric disease, so homozygotes in this dataset argue against a fully penetrant severe recessive phenotype and belong in the clinical picture. This is interpretive signal, not a classification.

Ancestry groupAllele freq.AC / ANHom.Carrier est.
African / African American0.048%36 / 74,9461~1 in 1040
Remaining individuals0.0032%2 / 62,4640~1 in 15620
Admixed American · under-sampled0.0017%1 / 60,0120
European (non-Finnish) · under-sampled0.000085%1 / 1,180,0360

Source: gnomAD r4, retrieved 2026-08-21. Values are allele frequencies. The carrier estimate is derived from the allele frequency (Hardy-Weinberg, ~2·AF) and is an approximation, not a published figure — where a published carrier frequency exists it outranks this column and is cited on the card.

Full Variant Card

WFS1 Wolframin — W371G Variant Card

Molecular Atlas Pilot · RareResearch.AI · Generated by wolfram-variant-card skill

Tryptophan → Glycine at position 371. Transmembrane helix 3. ClinVar Uncertain significance, AlphaMissense 0.908, DynaMut2 ΔΔG -2.34 kcal/mol (destabilising).


Identity

FieldValue
VariantW371G (p.Tryptophan371Glycine)
DNA changec.1111T>G
Gene · ProteinWFS1 · Wolframin (890 aa)
UniProtO76024 · WFS1_HUMAN
ClinVar accessionVCV001520543
Amino acid changeTryptophan (W) → Glycine (G)

Structural Context

FieldValue
AlphaFold modelAF-O76024-F1, v6
pLDDT at residue 37180.25 — well-folded
DomainTransmembrane helix 3
Position contextInside Transmembrane helix 3 · position 371 is bilayer-embedded
IDR flagNo — pLDDT above 50 threshold

UniProt features at this position:

(none catalogued)

Position 371 sits in a transmembrane helix (Transmembrane helix 3). Wolframin has eleven such helices anchoring it in the ER membrane; substitutions inside the bilayer-embedded segments can disrupt helix packing, lipid contacts, and the overall ER topology of the protein. The wild-type residue is bulky aromatic (tryptophan — indole ring); the mutant is small/flexible (glycine — backbone flexibility, no sidechain). The chemistry shift implies altered local packing, hydrogen-bonding, and/or electrostatics at this site.


Computational Predictions

AlphaMissense

FieldValue
am_pathogenicity0.9081
am_classlikely pathogenic
InterpretationLikely pathogenic (threshold 0.564)

DynaMut2

FieldValue
ΔΔG (kcal/mol)-2.34 (Destabilising)
Job ID178092106001
Result URLJob 178092106001 · retrieved 2026-06-08 — result self-hosted by RareResearch.AI (Biosig no longer serves this page)

Clinical Evidence

Inheritance and scope

Uncertain significance — phenotype scope not stated in ClinVar

ClinVar classifies this variant as Uncertain significance, but does not state what it is classified for. ClinVar records no condition for this variant. A classification without a phenotype and an inheritance mode cannot be read as a statement about Wolfram syndrome risk or severity.

Phenotype scope is interpretation of submitted records. The computed values on this card (AlphaMissense, DynaMut2 ΔΔG, pLDDT) are measurements of the model, not of a patient. Presentation cannot be generalised from neighbouring variants: one nucleotide over can present very differently. Structural similarity supports a mechanistic hypothesis, never a phenotype claim.

FieldValue
ClassificationUncertain significance
Review statuscriteria provided, single submitter
Last evaluated2021/09/20 00:00
InheritanceInheritance pattern not specified in ClinVar entry; WFS1 has both AD and AR presentations.
WFS1 variant landscapeW371G is 1 of ~326 pathogenic-spectrum variants in WFS1 (out of 2,243 catalogued in ClinVar)

(no conditions catalogued)


Research Path Decision Tree

ΔΔG < 2  + binding site affected   →  CATEGORY 3 — docking experiments
ΔΔG 2–4                            →  CATEGORY 2 — pharmacological chaperones
ΔΔG > 4                            →  CATEGORY 1 — gene therapy
pLDDT < 50                         →  CATEGORY 5 — IDR, experimental only
Stable fold + functional site hit  →  CATEGORY 4 — site-specific docking

Final Schema Categorization

Category 2 — Moderately Destabilizing

<strong>Category 2 — Moderately Destabilizing</strong><br/><br/>|ΔΔG|=2.34 in the 2–4 range. Pharmacological chaperone candidate.


Files in this folder

  • AF-O76024-F1-model_v6.pdb — AlphaFold structure
  • W371G_molstar_viewer.html — interactive 3D viewer (auto-highlights position 371 with ball-and-stick + neighbors within 5Å)
  • W371G_variant_card.md — this card (source of truth)
  • W371G_variant_card.html — styled printable card
  • W371G_dynamut2_summary.html — clean offline DynaMut2 result card
  • dynamut2_result.json — structured result data
  • dynamut2_result_page.html — local snapshot of the Biosig result page (asset URLs absolutized)
  • W371G_wildtype_interactions.pse / W371G_mutant_interactions.pse — PyMOL sessions

Generated by wolfram-variant-card skill · RareResearch.AI Molecular Atlas Every assumption documented. Every score sourced.

Therapeutic Strategy Handoff · prediction

Feed this card to Wolfram Intelligence

Download the W371G PDF below and upload it to Wolfram Intelligence to generate therapeutic-strategy proposals — guanidinium mimetics, sigma-1 agonist docking, NAC thiol-capping. NAC is already on the bench-testing list.

Download W371G PDF card ↓Strategies are AI-generated predictions, not validated therapeutics.